News

On January 3, 2024, China-Indonesia Chronic Disease Education and Management Exchange Symposium was hosted by the Wuxi Medical Device Industry Association and BioHermes Bio & Medical Technology Co., Ltd. in Wangzhuang Science and Technology Innovation Park. The event provided a platform for experts to address challenges and share advancements in chronic disease management between the two countries. The Symposium was hosted by Yan Liu, General Manager of Wuxi BioHermes Bio& Medical Technology Co., Ltd. and Vice President of Wuxi Medical Device Industry Association. Dr. Qian, from Department of Disease Control and Prevention, and Cai, from Department of Chronic Non-infectious Disease Prevention and Control, Nantong Center for Disease Control and Prevention, introduced knowledge about chronic diseases and conducted relevant exchanges based on the current status of chronic disease management in Indonesia, Wuxi City, and Nantong City. This forum also invited experts to participate in the discussions. With the theme of "New Situation, New Tasks, and New Starting for Chronic Disease Management", Director Cai started from the current situation of chronic disease prevalence and the aging population in Nantong City, and combined with the "Healthy China Action 2019-2030" planning outline, emphasized the importance of standardized management and patient self-management for chronic diseases. It was mentioned that the current severe challenges facing Chinese chronic disease management mainly include the lack of primary medical experts; soaring demand for health services; low service efficiency; and insufficient technology and capacity building. He also pointed out that exploring new form of chronic disease management requires breaking the shortcomings of the separation of prevention and treatment in the traditional chronic disease management, combining Internet technology and optimizing the distribution of medical resources to improve the service of medical and health institutions, integrating prevention and treatment. Dr. Eva gave a detailed introduction to the prevalence of major chronic diseases in Indonesia from 2013 to 2018. This includes an analysis of the causes of changes in disease conditions over the years, and points out that the main problems currently faced by Indonesia are low disease screening detection rates and low treatment effectiveness. In response to these problems, the Indonesian government has also taken many measures, including strengthening the construction of the medical system, strengthening health education and publicity, and increasing screening of target groups, which have reduced the mortality and disability rates related to chronic diseases, and alleviated the financial burden caused by chronic diseases. With the theme of "Type 2 Diabetes Control", Director Qian introduced the regional distribution and population prevalence of type 2 diabetes in China based on the current situation of type 2 diabetes prevention and control in Wuxi City, and put forward the diabetes management needs for diabetic patients. Increase the public awareness of diabetes and actively carry out diabetes screening which play a vital role in early detection, early diagnosis and early treatment of diabetes patients. The symposium fostered discussions on chronic disease management, diabetes control, and market entry strategies for Indonesian collaboration. It provided Chinese and Indonesian companies an opportunity to deepen their mutual understanding, fostering economic contributions through bilateral commercial partnerships. As the symposium concluded, the hope spread for successful collaboration between medical companies from China and Indonesia, driving advancements in chronic disease prevention and management while accelerating economic development.

BioHermes has made significant strides in the medical technology sector in the final season of 2023, showcasing our innovative products and fostering partnerships with potential collaborators. Our participation in multiple international events, such as HOSPITAL EXPO in Indonesia, CMEF in Shenzhen, and Medica in Germany, demonstrates our commitment to advancing medical technology on a global scale. Through our efforts, BioHermes has not only contributed to the advancement of medical technology but also supported initiatives to improve healthcare worldwide. October 18-21, 2023: HOSPITAL EXPO in Indonesia The HOSPITAL EXPO in Indonesia emerged as a focal point of collaboration and innovation in the medical field from October 18th to 21st. The exhibition attracted significant international attention, with nearly 590 companies from countries including China, Australia, Belgium, Indonesia, Japan, South Korea, Malaysia, Russia, Singapore, and Thailand. In particular, 180 Chinese companies made a strong showing. BioHermes, dedicated to research and development of IVD products, showcased our Glycohemoglobin analyzer product line in this Expo. Our booth became a popular hub of medical product inquiry and industrial information exchange, laying a solid foundation for future trade cooperation. October 28-31, 2023: CMEF in Shenzhen Later in October, from the 28th to the 31st, the Shenzhen CMEF opened its doors under the banner "Innovative Technology Leads the Future." The event highlighted cutting-edge technologies with the robust participation of over 4,000 companies from more than 130 countries and regions. Coinciding with the exhibition were over 70 themed conferences focusing on industry policies and hot topics. BioHermes displayed our Glycated Hemoglobin Analyzer, ICU, and anesthesia products. We also offered complimentary HbA1c testing for attendees and demonstrated a live comparison between our POCT and HPLC Glycohemoglobin analyzers' results. November 14, 2023: World Diabetes Day On World Diabetes Day, BioHermes partnered with hospitals across various provinces to offer free HbA1c test to raise awareness and promote diabetes diagnosis and preventive measures for diabetes. This activity aimed to enhance public understanding of diabetes, encouraging proactive screening and timely treatment. November 13-16, 2023: Medica in Germany The Medica in Germany, taking place from November 13th to 16th, brought together an impressive gathering of over 5,300 exhibitors from more than 70 countries and regions. The event was attended by tens of thousands of professionals from the medical industry, showcasing a multitude of innovative technologies and blending avant-garde academic thought. Our BioHermes team displayed our comprehensive range of Glycosylated Hemoglobin Device alongside our specialized ICU and anesthesia series. Our presentation drew significant interest from potential collaborators, leading to numerous expressions of interest in partnerships. Established partners also seized this opportunity to enhance cooperation and strengthen relationships with BioHermes. BioHermes is proud of all the efforts of improving public health, and waiting for more reliable partners joining us.

The world's largest and most influential annual scientific conference and clinical event AACC will be held at the Anaheim Convention Center in California from July 23rd to 27th. This event offers attendees a unique opportunity to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry analysis, laboratory management, and other fields, providing insights into cutting-edge technologies, groundbreaking research, and significant changes. We would like extend our most gracious invitation to all distinguished guests and esteemed professionals to join us at our booth 1383 to have a communication about our products and public health. What will you discover from BioHermes? Comprehensive product range of HbA1c Analyzer for diabetes management: The first handheld Glycated Hemoglobin Analyzer and Benchtop Glycohemoglobin HbA1c Analyzer utilizing gold standard HPLC methodology. Obstetrics and gynecology: IGFB-1/fFN joint test ICU/anesthesiology products: laryngeal mask, etco2 nasal cannula Please come to explore more products and information, see you!

FIME ( Florida International Medical Expo ), the world's leading international medical exhibition and conference, and the largest medical trade fair in the Americas, made a grand show at the Miami Beach Convention Center from June 21st to 23rd. With thousands of exhibitors from over fifty countries, the event attracted numerous healthcare professionals from more than a hundred countries and regions. BioHermes, a prominent player in medical industry, seized the spotlight with its remarkable lineup of products and solutions, captivating attendees with their visionary approach. With a full range of glycohemoglobin products certified by NGSP, IFCC, and FDA, as well as a portfolio of obstetrics and gynecology, ICU/anesthesiology products featuring multiple patents including US invention patents, BioHermes was showcasing their product competitiveness and brand reputation. Throughout the exhibition, Biohermes captured the attention of numerous industry peers, sharing insights and making productive discussions on potential partnership opportunities. Visitors were pleasantly surprised by the comprehensive solution offered by BioHermes in the realm of diabetes management, encompassing an array of cutting-edge products. These included portable A1c EZ 2.0 Handheld Glycohemoglobin Meter, automated A1cChek Express /Pro Touch Screen Benchtop Glycohemoglobin Devices and BH 60 High Throughput Laboratory HPLC HbA1c Analyzer adopting gold standard High Performance Liquid Chromatography methodology. BioHermes Mission: To provide faster, more convenient, more accurate, and more affordable testing products for in vitro diagnostics, empowering us to effectively prevent and control diseases. Looking Ahead: With the successful conclusion of this exhibition at FIME, Biohermes looks forward to meet more esteemed attendees at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo on July 23-27 in Anaheim.

The 85th China International Medical Equipment Fair (2021 CMEF Autumn Fair) will be held in Shenzhen International Convention and Exhibition Center on October 13-16, 2021. Hereby, we sincerely invite our valuable partners and friends to visit to our booth at Hall 14, B17, with the expectation to discover opportunities for cooperation, as well as deepen the existing partnership into more extensive area. About CMEF China International Medicinal Equipment Fair (CMEF) is the largest exhibition of medical equipment, related products and services in the Asia-Pacific region. The exhibition widely covers ten thousands of products such as medical imaging, in vitro diagnosis, electronics, optics, first aid, rehabilitation nursing, medical information technology and outsourcing services, and it provides services to the entire medical industry chain from the source to the end of the medical equipment industry in a direct and all-round way. About BioHermes BioHermes, as the high-tech IVD enterprise with unique HbA1c testing technology, focus on providing the most convenient, effective and affordable HbA1c testing to the people around the world, thus to prevent diabetes and its complications globally.

The 81st China International Medicinal Equipment Fair (CMEF) will be held during May 14 to 17, 2019 at National Convention & Exhibition Center of Shanghai. Hereby, we sincerely invite our valuable partners and friends to visit to our booth at Hall 3, 3K18, with the expectation to discover opportunities for cooperation, as well as deepen the existing partnership into more extensive area. About CMEF China International Medicinal Equipment Fair (CMEF) is the largest exhibition of medical equipment, related products and services in the Asia-Pacific region. The exhibition widely covers ten thousands of products such as medical imaging, in vitro diagnosis, electronics, optics, first aid, rehabilitation nursing, medical information technology and outsourcing services, and it provides services to the entire medical industry chain from the source to the end of the medical equipment industry in a direct and all-round way. About BioHermes BioHermes, as the high-tech IVD enterprise with unique HbA1c testing technology, focus on providing the most convenient, effective and affordable HbA1c testing to the people around the world, thus to prevent diabetes and its complications globally.

19 distributors from 10 countries had come to China, to attend the BioHermes Global Distributor Meeting of 2019, which was held on 22th and 23th, March. The meeting and serial events took place in the two cities of Guangzhou and Nanchang. As recorded, so far, the handheld HbA1c analyzer has met with great success in the global market and more than 50,000 units have been placed in more than 60 countries and has benefited tens of thousands of people worldwide. At the very start of the meeting, BioHermes International Sales & Marketing team had acknowledged all the persistent efforts from the valuable overseas distributors, without who, all these achievements cannot be accomplished. In the year of 2019, BioHermes will focus on the promotion of our newly launched benchtop glycohemoglobin analyzer, A1cChek Pro., to extend our application scenarios to laboratories and hospitals in larger scale. Therefore, a most comprehensive exposition of A1cChek Pro had also been presented to the distributors, including the analyzer`s distinct features as well as the powerful cloud service. The meeting is also a rare opportunity for distributors different countries to conduct sales and marketing exchanges. Several distributors with great success had been invited to give presentation about their successful promotion experiences in their own markets, which was considered really beneficial to other distributors for their future work and a further understanding of HbA1c testing situations globally. Also several satellite academic forums organized by BioHermes were held during the well-known IVD event of CACLP EXPO in Nanchang. Renowned diabetologist from authoritative hospital was invited to give a insight presentation of diabetes and HbA1c testing to our distributors. The serial events of the 2019 distributors meeting were ended with an acknowledgment banquet, with the theme [2019, New Journey for BioHermes, New Start for Our Partnership". Both domestic and overseas distributors were gathered together joyfully, as well as the senior management team of BioHermes, to enjoy this memorable moment once a year and recognize the consensus achieved during the past days.